PEPFAR对国家公共卫生研究所的投资:通过强化系统控制HIV
本文阐述国家公共卫生研究所(NPHI)在终结HIV/AIDS公共卫生威胁中的作用,并说明PEPFAR对NPHI的投资方向,包括强化HIV相关公共卫生系统及直接支持针对性HIV活动。文中以莫桑比克和赞比亚两个非洲NPHI与PEPFAR的合作为例,指出PEPFAR对NPHI的投资可撬动全球卫生安全领域的其他投资。
要点
- NPHI承担参比实验室、监测、疫情准备与响应、研究、公共卫生人力及科学沟通等公共卫生职能。
- PEPFAR投资NPHI既强化HIV相关公共卫生系统,也直接支持国家调查、参比实验室服务和人力培训等针对性HIV活动。
- PEPFAR对NPHI的投资可与其他全球卫生安全投资形成协同。
核心结论
- NPHI正运用公共卫生专业能力,协同卫生部、国家艾滋病委员会、双边和多边伙伴、私营部门及民间社会等利益相关方,助力到2030年终结HIV/AIDS作为公共卫生威胁。
- PEPFAR对NPHI的投资可撬动全球卫生安全领域的其他投资。
研究设计与样本
- 本文为综述性文章,以莫桑比克和赞比亚两个非洲NPHI与PEPFAR的多年合作为例进行阐述。
主要发现
- PEPFAR对NPHI的投资包括强化HIV相关公共卫生系统,如人力发展、参比实验室认证和基础设施改善。
- PEPFAR对NPHI的投资还包括直接支持针对性HIV活动,如国家调查、参比实验室服务和人力培训。
临床怎么用
- 感染科及HIV防控相关工作者可关注NPHI在参比实验室、监测和人力培训等方面的系统能力建设,并与PEPFAR等投资方协同推进HIV防控。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
National public health institutes (NPHIs) are governmental institutions with a public health mandate, which often includes reference laboratories, surveillance, outbreak preparedness and response, research, public health workforce, scientific communication to translate data into policy, and more. NPHIs are applying public health expertise to help end HIV/AIDS as a public health threat by 2030, in coordination with other key stakeholders, including not just ministries of health but also national AIDS councils, bilateral and multilateral partners, the private sector, civil society, and others. The President's Emergency Plan for AIDS Relief (PEPFAR) has invested in NPHIs to strengthen their HIV-related public health systems (eg, workforce development, accreditation of reference laboratories, improvement of infrastructure) and directly support targeted HIV activities (eg, national surveys, reference laboratory services, workforce training). Here, we highlight 2 examples of African NPHIs that have partnered with PEPFAR over the years (Mozambique and Zambia). PEPFAR's investments in NPHIs can leverage other investments in global health security.
引用
- Verani AR, Samo Gudo E, Chilengi R, et al. PEPFAR Investments in National Public Health Institutes: HIV Control Through Strong Systems. J Infect Dis. 2025. PMID: 40976854. doi:10.1093/infdis/jiaf339
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。